OptiBiotix appoints CEO Stephen O'Hara as CEO of subsidiary

Tue, 21st Feb 2023 14:15

(Alliance News) - OptiBiotix Health PLC on Tuesday said that Rene Kamminga, Chief Executive Officer of subsidiary OptiBiotix Ltd, will leave the business next week Tuesday.

The York, England-based probiotics developer tackling obesity, cardiovascular diseases and lifestyle conditions announced it appointed its CEO Stephen O'Hara as CEO of the subsidiary.

O'Hara "will lead a minor restructuring of the business," OptiBiotix added.

Optibiotix shares were 2.8% lower at 12.89 pence each in London on Tuesday afternoon.

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Related Shares

More News

30 Apr 2024 16:55

OptiBiotix Health inks manufacturing deal with KAG Industries

(Sharecast News) - Life sciences company OptiBiotix Health announced on Tuesday that its its Indian subsidiary, OptiBiotix Health India (OHI), has ent...

30 Apr 2024 15:56

EARNINGS AND TRADING: Card Factory profit climbs; Pebble "consistent"

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

25 Mar 2024 17:08

OptiBiotix Health raises GBP1.4 million to invest in "driving sales"

(Alliance News) - OptiBiotix Health PLC on Monday said it has raised GBP1.4 million through a placing and subscription of shares.

13 Mar 2024 20:49

EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

13 Mar 2024 14:28

OptiBiotix signs partnership with India's Dr Morepen

(Sharecast News) - Life science company OptiBiotix Health announced the signing of a partnership agreement with Dr Morepen on Wednesday, for the distr...